PALO ALTO, Calif., Feb. 27, 2020 /PRNewswire/ -- Kodiak
Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical
company specializing in novel therapeutics to treat chronic,
high-prevalence retinal diseases, announced today that management
will present at the following upcoming investor conferences:
- Cowen 40th Annual Health Care Conference in Boston, MA on Wednesday, March 4 at 10:00 a.m. Eastern Time
- Barclays Global Healthcare Conference in Miami, FL on Wednesday,
March 11 at 3:50 p.m. Eastern
Time
A live webcast of both presentations will be available on the
"Investors & Media" section of Kodiak's website at
http://ir.kodiak.com/ and will remain available for replay for a
limited time following each event.
About Kodiak Sciences Inc.
Kodiak (Nasdaq: KOD) is a clinical stage biopharmaceutical
company specializing in novel therapeutics to treat chronic,
high-prevalence retinal diseases. Founded in 2009, we are focused
on bringing new science to the design and manufacture of next
generation retinal medicines to prevent and treat the leading
causes of blindness globally. Our ABC Platform™ uses molecular
engineering to merge the fields of antibody-based and
chemistry-based therapies and is at the core of Kodiak's discovery
engine. Kodiak's lead product candidate, KSI-301, is a novel
anti-VEGF antibody biopolymer conjugate being developed for the
treatment of retinal vascular diseases including age-related
macular degeneration, a leading cause of blindness in elderly
patients, and diabetic eye diseases, a leading cause of blindness
in working-age patients. Kodiak has leveraged its ABC Platform to
build a pipeline of product candidates in various stages of
development including KSI-501, our bispecific anti-IL-6/VEGF
biopolymer conjugate for the treatment of neovascular retinal
diseases with an inflammatory component, and we are expanding our
early research pipeline to include ABC Platform based triplet
inhibitors for multifactorial retinal diseases such as dry AMD and
glaucoma. Kodiak is based in Palo Alto, CA. For more
information, please visit www.kodiak.com.
"Kodiak," "ABC Platform" and the Kodiak logo are registered
trademarks or trademarks of Kodiak Sciences Inc. in various
jurisdictions.
View original
content:http://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-upcoming-conferences-301012287.html
SOURCE Kodiak Sciences Inc.